NeuroBrave Company Profile
NeuroBrave, founded in 2020 and based in Jerusalem, is a privately held, venture capital-backed company with 40 employees that develops an AI platform leveraging hardware and wearables to analyze neuro-biomarkers for emotional stress, anxiety, burnout, and productivity through real-time cloud streaming, scientifically validated biomarkers, and consumer recommendations, serving primarily the clinics/outpatient services industry and related healthtech sectors, having completed multiple funding rounds including seed and accelerator/incubator deals.
Company Overview
Year Founded: 2020
Status: Private
Employees: 40
Latest Deal Type: Accelerator/Incubator
Investors: 7
General Information
NeuroBrave is a developer of an artificial intelligence platform designed for analyzing neuro-biomarkers or insights using any available hardware and wearables. The platform includes datasets for human cognitive and emotional experiences, a real-time streaming cloud-based infrastructure, signal processing, and numerous accurate and scientifically validated AI biomarkers for emotional stress, anxiety, burnout, productivity, and a consumer recommendation system. This enables clients to take charge of their well-being.
Website: www.neurobrave.com
Ownership Status: Privately Held (backing)
Financing Status: Venture Capital-Backed
Corporate Office:
- 24th Derech Chevron Street
- Jerusalem 9354212
- Israel
Primary Industry: Clinics/Outpatient Services
Other Industries:
- Other Devices and Supplies
- Other Healthcare Technology Systems
- Application Software
Verticals:
- Big Data
- LOHAS & Wellness
- SaaS
- Artificial Intelligence & Machine Learning
- HealthTech
- Mobile
Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Status | Stage |
|---|---|---|---|---|---|
| Accelerator/Incubator | 09-Jul-2024 | Completed | Generating Revenue | ||
| Early Stage VC | 23-Feb-2024 | Completed | Generating Revenue | ||
| Seed Round | 01-Nov-2022 | Completed | Generating Revenue | ||
| Seed Round | 02-Aug-2021 | $1.2M | $1.2M | Completed | Generating Revenue |
| Accelerator/Incubator | 19-Apr-2021 | Completed | Generating Revenue |
Investors (Partial List)
- Google AI Startups Fund (Accelerator/Incubator)
- Italian Angels for Growth (Angel Group)
- NewGate Capital (Venture Capital)
- NewGate Capital Partners (PE/Buyout)
- VentureIsrael (Venture Capital)
Competitors
- Neurable (Boston, MA)
- LifeQ (Alpharetta, GA)
- Arctop (Los Angeles, CA)
- iMotions (Copenhagen, Denmark)
FAQs
When was NeuroBrave founded?
NeuroBrave was founded in 2020.
Where is NeuroBrave headquartered?
NeuroBrave is headquartered in Jerusalem, Israel.
What is the size of NeuroBrave?
NeuroBrave has 40 total employees.
What industry is NeuroBrave in?
NeuroBrave’s primary industry is Clinics/Outpatient Services.
Is NeuroBrave a private or public company?
NeuroBrave is a Private company.
What is NeuroBrave’s current revenue?
The current revenue for NeuroBrave is not disclosed.
How much funding has NeuroBrave raised over time?
NeuroBrave has raised $10M.
Who are NeuroBrave’s investors?
Google AI Startups Fund, Italian Angels for Growth, NewGate Capital, NewGate Capital Partners, and VentureIsrael are among the investors who have invested in NeuroBrave.
Who are NeuroBrave’s competitors?
Neurable, LifeQ, Arctop, and iMotions are competitors of NeuroBrave.